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ABSTRACT 
AIM: 
Ganoderma sp, the causal pathogen of the basal stem rot (BSR) disease of oil palm, secretes 
extracellular hydrolytic enzymes. These play an important role in the pathogenesis of BSR by 
nourishing the pathogen through the digestion of cellulose and hemicellulose of the host 
tissue. Active suppression of hydrolytic enzymes secreted by Ganoderma boninense by 
various naturally occurring phenolic compounds and estimation of their efficacy on pathogen 
suppression is focused in this study. 
METHODS AND RESULTS: 
Ten naturally occurring phenolic compounds were assessed for their inhibitory effect on the 
hydrolytic enzymes of G. boninense. The enzyme kinetics (Vmax and Km ) and the stability 
of the hydrolytic enzymes were also characterized. The selected compounds had shown 
inhibitory effect at various concentrations. Two types of inhibitions namely uncompetitive 
and noncompetitive were observed in the presence of phenolic compounds. Among all the 
phenolic compounds tested, benzoic acid was the most effective compound suppressive to the 
growth and production of hydrolytic enzymes secreted by G. boninense. The phenolic 
compounds as inhibitory agents can be a better replacement for the metal ions which are 
known as conventional inhibitors till date. The three hydrolytic enzymes were stable in a 
wide range of pH and temperature. 
CONCLUSION: 
These findings highlight the efficacy of the applications of phenolic compounds to control 
Ganoderma. 
SIGNIFICANCE AND IMPACT OF THE STUDY: 
The study has proved a replacement for chemical controls of G. boninense with naturally 
occurring phenolic compounds. 
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